HIGHLIGHTS
- who: Franziska Schauer and colleagues from the Osaka City University, Japan have published the paper: Hemidesmosomal Reactivity and Treatment Recommendations in Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid—A Retrospective, Monocentric Study, in the Journal: (JOURNAL)
- what: The authors analysed a cohort of eight patients and characterized their BPassociated hemidesmosomal reactivity, along with the disease manifestations and treatment options for ICI-BP.
- future: Since both patient cohorts are rather small more studies are required to define the median time of BP onset.
SUMMARY
ICI-induced bullous pemphigoid (ICI-BP), which . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.